首页> 外文期刊>Mini-Reviews in Medicinal Chemistry >The Design of G-quadruplex Ligands as Telomerase Inhibitors
【24h】

The Design of G-quadruplex Ligands as Telomerase Inhibitors

机译:G-四链体配体作为端粒酶抑制剂的设计

获取原文
获取原文并翻译 | 示例
       

摘要

Guanine-rich repetitive DNA sequences are of particular importance at the ends of chromosomes,nwhere they are associated with a number of proteins to form telomeres. Their function is in large part to protectnchromosomal ends from unwanted degradation and chromosomal fusions, although in normal somatic cellsntelomeres progressively shorten, eventually becoming non-proliferating and consequently these cells have anfinite lifetime. By contrast tumour cell telomeres are maintained in length so that tumour cells are effectivelynimmortalised. The reverse transcriptase enzyme telomerase is activated in over 80% of tumour cells, and itnundertakes the synthesis of further telomeric DNA repeats, so directly maintaining telomeres. The inhibition ofntelomerase leads to the senescence and eventual apoptosis of tumour cells, and thus telomerase is an attractiventarget for selective chemotherapy. This review describes an approach to the inhibition of telomerase thatninvolves the folding of telomeric DNA into a four-stranded quadruplex structure, held together by Hoogsteennhydrogen-bonded arrays of guanine bases. The formation of a quadruplex structure at the 3' end of telomericnDNA effectively hinders telomerase from adding further repeats. A number of small-molecule ligands arendescribed that stabilise quadruplex formation, and which result in telomerase inhibition. Implications for anti-ntumour therapy with such molecules are discussed, and the particular challenges and problems discussed.
机译:富含鸟嘌呤的重复性DNA序列在染色体末端特别重要,在那里它们与多种蛋白质结合形成端粒。它们的功能主要是保护染色体末端免受有害降解和染色体融合,尽管在正常的体细胞中端粒逐渐缩短,最终变得不增殖,因此这些细胞具有无限的寿命。相反,肿瘤细胞端粒的长度保持不变,从而使肿瘤细胞有效地被金属化。逆转录酶端粒酶在超过80%的肿瘤细胞中被激活,并且不参与其他端粒DNA重复序列的合成,因此直接维持端粒。端粒酶的抑制导致肿瘤细胞的衰老和最终的细胞凋亡,因此端粒酶是选择性化疗的有吸引力的靶标。这篇综述描述了一种抑制端粒酶的方法,该方法涉及端粒DNA折叠成四链四链体结构,该结构由鸟嘌呤碱基的Hoogsteenn氢键阵列结合在一起。在端粒DNA 3'端形成四链体结构有效地阻止了端粒酶增加其他重复序列。描述了许多稳定四链体形成并导致端粒酶抑制的小分子配体。讨论了用此类分子进行抗肿瘤治疗的意义,并讨论了具体的挑战和问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号